Elevance Health Stock Forecast

Stock Price Forecast

According to 22 analysts polled by S&P Global, Elevance Health stock has a consensus rating of "Buy" and an average price target of $449.1. The average 1-year stock price forecast is 15.65% higher than the current stock price, while the lowest is $393 (+1.20%) and the highest is $492 (+26.69%).

Price Target: $449.1 (+15.65%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$393	$449.1	$457	$492
Change	+1.20%	+15.65%	+17.68%	+26.69%

Analyst Ratings

The average analyst rating for Elevance Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	11	11	11	12	12	12
Buy	3	3	3	3	2	2
Hold	8	8	8	7	8	8
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	22	22	22	22	22	22

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Whit Mayo Leerink Partners	Leerink Partners	Hold Reiterates $364 → $395	Hold	Reiterates	$364 → $395	+1.72%	Jul 17, 2026
Ryan Langston TD Cowen	TD Cowen	Buy Reiterates $465	Buy	Reiterates	$465	+19.74%	Jul 17, 2026
David Windley Jefferies	Jefferies	Buy Maintains $391 → $450	Buy	Maintains	$391 → $450	+15.88%	Jul 16, 2026
Scott Fidel Goldman Sachs	Goldman Sachs	Hold Maintains $370 → $395	Hold	Maintains	$370 → $395	+1.72%	Jul 16, 2026
Erin Wright Morgan Stanley	Morgan Stanley	Hold Reiterates $404	Hold	Reiterates	$404	+4.03%	Jul 16, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

195.89B

from 199.13B

-1.63%

from 199.13B

Revenue Next Year

200.08B

from 195.89B

2.14%

from 195.89B

EPS This Year

27.11

from 30.29

-10.49%

from 30.29

EPS Next Year

29.65

from 27.11

9.34%

from 27.11

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	138.64B	156.60B	171.34B	176.81B	199.13B	195.89B
Revenue Growth	13.77%	12.95%	9.41%	3.19%	12.62%	-1.63%
Net Income	6.16B	5.89B	5.99B	5.98B	5.66B	4.53B
EPS	-	-	-	-	30.29	27.11
EPS Growth	-	-	-	-	-8.32%	-10.49%
Forward PE	16.70	16.14	13.17	11.25	13.09	14.32
Dividend / Share	4.52	5.12	5.92	6.52	6.84	6.89
Dividend Growth	-	13.27%	15.62%	10.14%	4.91%	0.78%
Free Cash Flow	3.61B	8.43B	3.00B	7.26B	3.40B	6.33B
No. Analysts	-	-	-	-	-	12

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	199.1B
Avg	195.9B
Low	192.7B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	-0.0%
Avg	-1.6%
Low	-3.2%

EPS Forecast

Chart

EPS	2026	2027	2028
High	28.25
Avg	27.11
Low	26.79

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-6.7%
Avg	-10.5%
Low	-11.6%